January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...

T.J. Atchinson is first person with a spinal cord injury to undergo procedure. June 2, 2011 -- Dr. Donald Leslie, medical director at the Shepherd Center in Atlanta, has high hopes. "We want to cure ...

Bioluminescence Imaging in PAD The new technique assists in creating new or additional blood vessels for individuals with extensively narrowed or clogged arteries by allowing simple imaging to view ...

One of the most enduring goals in regenerative medicine is deceptively simple: replace a person's damaged or dying cells with ...